![]() |
![]() Visitors & Friends > News > Releases > Science > Article News Releases October 6, 2001 Media
Contact: Denine Hagen (858) 509-4871,
cell - (858) 336-4508 Editors Note: Image of the joint cartilage available at: www.soe.ucsd.edu UCSD
Bioengineers Fabricate Joint Cartilage
Robert
Sah, professor of bioengineering at the UCSD Jacobs School of Engineering, led
the study, conducted by graduate students Travis Klein and Kelvin Li and staff
researcher Barb Schumacher at UCSD, in collaboration with Professors Koichi
Masuda and Eugene Thonar of Rush Medical College. Klein will describe the
results at the Biomedical Engineering Society annual meeting at 2:15 p.m. on
Saturday, October 6 at the Sheraton Imperial in Durham, North Carolina. "We've
designed a tissue made up of different types of juvenile cartilage cells with
the notion that the tissue could be implanted into a patient and grow up to
conform to the specific geometry of the individual's joint," said Sah.
Next steps in the research will be to conduct animal trials to determine the
efficacy of such an implant treatment. Cartilage
is the body's shock absorber, a cushion of durable tissue that protects the
knee from a lifetime of walking, bending and running. Though just a few
millimeters thick, cartilage is nevertheless quite complex, consisting of a
surface, middle and deep region, each with its own distinct composition and
structure. In previous research, Sah detailed the mechanical properties
of cartilage and found that it is soft at the surface, but 25 times stiffer in
the deep regions. Meanwhile, Barbara Schumacher, then at Rush Medical
College, found that the cells in the surface region make a key protein, called
Superficial Zone Protein, which is a major lubricant of joints. Using
this data, bioengineers at UCSD developed a map for how to organize different
types of chondrocytes to mimic the stratified nature of cartilage tissue.
They then grew this cell mix together using the ARC (Alginate Recovered
Chondrocyte) method developed at Rush, which suspends cells in a gel until the
cells begin to form their own matrix or scaffolding. The gel is
then removed, leaving an entirely biological tissue. In
laboratory tests, the researchers found that the cells at the surface of their
engineered tissue effectively secreted the key molecule, Superficial Zone
Protein, needed to lubricate the joint. In addition, the cells at the
surface were making tissue that was softer and had a less dense matrix, while
the cells in the deeper regions were spaced further apart and had a more
densely packed matrix, which made the tissue stiffer. The
researchers believe that the engineered tissue will mature like cartilage does
naturally in humans. During fetal development, cartilage cells are
densely packed, and the matrix is loosely knit. But as a child grows and
the matrix supporting the cartilage gets stronger, cartilage cells spread out.
By the time an individual reaches adulthood, the cartilage is mature, the
cells become less active, and the tissue is about four fold stiffer than
during early development. The engineered tissue is like immature
cartilage, and the researchers believe this will give the implant an advantage
because as it continues to mature, it is likely to integrate well and conform
to fit with the patient's surrounding cartilage and joint tissue. The research is funded by the National Aeronautics and Space Administration (NASA), the National Science Foundation (NSF), The Rush Arthritis and Orthopedics Institute and the Grainger Foundation.
|
Copyright ©2001 Regents of the University of California. All rights reserved. Last modifed
|